91- Sokka T, Kautiainen H, Pincus T, Toloza S, da Rocha Castelar Pinheiro G, Lazovskis J, et al.
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25
countries in the QUEST-RA database. Ann Rheum Dis. 2009;68(11):1666–72. - Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness,
and sociodemographic disadvantage characterize RA patients with fi bromyalgia. J Rheumatol.
2004;31(4):695–700. - Pincus T. Formal educational level—a marker for the importance of behavioral variables in
the pathogenesis, morbidity, and mortality of most diseases? J Rheumatol.
1988;15(10):1457–60. - Maiden N, Capell HA, Madhok R, Hampson R, Thomson EA. Does social disadvantage
contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis.
1999;58(9):525–9. - Callahan LF, Pincus T. Formal education level as a signifi cant marker of clinical status in
rheumatoid arthritis. Arthritis Rheum. 1988;31(11):1346–57. - Callahan LF, Pincus T, Huston 3rd JW, Brooks RH, Nance Jr EP, Kaye JJ. Measures of activ-
ity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over
fi ve years. Arthritis Care Res. 1997;10(6):381–94. - Ruberman W, Weinblatt E, Goldberg JD, Chaudhary BS. Psychosocial infl uences on mortal-
ity after myocardial infarction. N Engl J Med. 1984;311(9):552–9. - Rose HM, Ragan C, et al. Differential agglutination of normal and sensitized sheep erythro-
cytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med. 1948;68(1):1–6. - Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements; the tart
cell and the L.E. cell. Proc Staff Meet Mayo Clin. 1948;23(2):25–8. - Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij
WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid
arthritis-specifi c autoantibodies. J Clin Invest. 1998;101(1):273–81. - Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis:
diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for
rheumatoid arthritis. Ann Intern Med. 2007;146(11):797–808. - Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of
the prevalence of arthritis and other rheumatic conditions in the united states. Part II. Arthritis
Rheum. 2008;58(1):26–35. - Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, et al. The diag-
nostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheu-
matoid factor, erythrocyte sedimentation rate, and c-reactive protein in patients with erosive
and non-erosive rheumatoid arthritis. Clin Dev Immunol. 2005;12(3):197–202. - Wolfe F, Michaud K. The clinical and research signifi cance of the erythrocyte sedimentation
rate. J Rheumatol. 1994;21(7):1227–37. - Wolfe F. The many myths of erythrocyte sedimentation rate and c-reactive protein.
J Rheumatol. 2009;36(8):1568–9. - Smedstad LM, Moum T, Guillemin F, Kvien TK, Finch MB, Suurmeijer TP, et al. Correlates
of functional disability in early rheumatoid arthritis: a cross-sectional study of 706 patients in
four European countries. Br J Rheumatol. 1996;35(8):746–51. - Sokka T, Pincus T. Erythrocyte sedimentation rate, c-reactive protein, or rheumatoid factor
are normal at presentation in 35–45% of patients with rheumatoid arthritis seen between 1980
and 2004: analyses from Finland and the united states. J Rheumatol. 2009;36(7):1387–90. - Wolfe F, Pincus T. The level of infl ammation in rheumatoid arthritis is determined early and
remains stable over the longterm course of the illness. J Rheumatol. 2001;28(8):1817–24. - Abelson B, Sokka T, Pincus T. Declines in erythrocyte sedimentation rates in patients with
rheumatoid arthritis over the second half of the 20th century. J Rheumatol. 2009;
36(8):1596–9. - Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have
signifi cantly better articular, radiographic, laboratory, and functional status in 2000 than in
1985. Arthritis Rheum. 2005;52(4):1009–19.
3 PROMs (MDHAQ/RAPID3) and Physician RheuMetric Measures